Q THERAPEUTICS, INC.

Basic Information

Q THERAPEUTICS, INC.
421 WAKARA WAY, STE 201
SALT LAKE CITY, UT, 84108

Company Profile

n/a

Additional Details

Field Value
DUNS: n/a
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Development of Astrocyte-Restricted Precursors for Cell Therapy and Drug Screenin

    Amount: $118,355.00

    DESCRIPTION (provided by applicant): The long-term objective of this research is to develop a cell therapy for the treatment of neurological disorders that are due to dysfunctional astrocytes. Current ...

    SBIR Phase I 2010 Department of Health and Human Services
  2. A novel technology for protein delivery to the CNS

    Amount: $126,563.00

    DESCRIPTION (provided by applicant): The long-term objective of this research is to develop a cell-based system for delivering therapeutic gene products to brain and spinal cord. Several candidate pro ...

    SBIR Phase I 2004 Department of Health and Human Services
  3. NUCLEAR/CYTOPLASMIC RATIO-EFFECTS ON EMBRYO DEVELOPMENT

    Amount: $49,996.00

    N/A

    SBIR Phase I 1992 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government